Quarterly report pursuant to Section 13 or 15(d)

Stock Option Plans

v3.7.0.1
Stock Option Plans
6 Months Ended
Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Option Plans

 NOTE 8 – STOCK OPTION PLANS

 

On February 7, 2014, the Company adopted the 2014 Equity Compensation Plan. Under this plan, the Company may issue options to purchase shares of common stock to employees, directors, advisors, and consultants. The aggregate number of shares that may be issued under this plan is 30,420,148. On April 16, 2015, the majority stockholder of the Company approved an increase in the Company’s 2014 Equity Compensation Plan by 15 million shares.

 

Under the terms of the 2014 Equity Compensation Plan and the 2006 Stock Incentive Plan (collectively, the “Plans”), incentive stock options may be granted to employees at a price per share not less than 100% of the fair market value at date of grant. If the incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Non-statutory stock options and restricted stock may be granted to employees, directors, advisors, and consultants at a price per share, not less than 100% of the fair market value at date of grant. Options granted are exercisable, unless specified differently in the grant documents, over a default term of ten years from the date of grant and generally vest over a period of four years.

 

A summary of stock option activity is as follows:

 

    Options     Weighted average exercise price     Weighted average remaining contractual term in years     Aggregate intrinsic value  
Outstanding January 1, 2016     34,167,354     $ 0.47       6.57     $ 974,066  
Exercisable January 1, 2016     34,167,354     $ 0.47       6.57     $ 974,066  
Canceled     -                          
Granted     6,156,580                          
Exercised     -                          
Forfeited     (3,501,965 )                        
Outstanding December 31, 2016     36,821,969     $ 0.41       5.94     $ 301,273  
Exercisable December 31, 2016     36,771,969     $ 0.41       5.94     $ 299,273  
Canceled     -                          
Granted     161,458                          
Exercised     -                          
Forfeited     -                          
Outstanding June 30, 2017     36,983,427     $ 0.40       5.44     $ 1,068,480  
Exercisable June 30, 2017     36,983,427     $ 0.40       5.44     $ 1,068,480  

 

The aggregate intrinsic value in the table above is before applicable income taxes and represents the excess amount over the exercise price option recipients would have received if all options had been exercised on December 31, 2016, based on a valuation of the Company’s stock for that day.

 

A summary of the Company’s non-vested options for the six-months ended June 30, 2017 and year ended December 31, 2016 are presented below:

 

Non-vested at January 1, 2016     -  
Granted     6,156,580  
Vested     (6,106,580 )
Forfeited     -  
Non-vested at December 31, 2016     50,000  
Granted     161,458  
Vested     (211,458 )
Forfeited     -  
Non-vested at June 30, 2017     -  

 

The Company estimates the fair value of stock options granted on each grant date using the Black-Scholes option valuation model and recognizes an expense ratably over the requisite service period. The range of fair value assumptions related to options issued were as follows for the periods ended:

 

    June 30, 2017     December 31, 2016  
    (Unaudited)        
Dividend yield     0.0 %     0.0 %
Risk-free rate     1.89% - 1.93 %     0.80% - 1.03 %
Expected volatility     231% - 232 %     141% - 225 %
Expected term     5 years        5 years  

 

The expected volatility was calculated based on the historical volatilities of publicly traded peer companies, determined by the Company, and the historical volatility of the Company. The risk-free interest rate used was based on the U.S. Treasury constant maturity rate in effect at the time of grant for the expected term of the stock options to be valued. The expected dividend yield was zero, as the Company does not anticipate paying a dividend within the relevant timeframe. Due to a lack of historical information needed to estimate the Company’s expected term, it was estimated using the simplified method allowed. In calculating the number of options issued in lieu of pay during the year ended December 31, 2016, the Company used assumptions comparable to December 31, 2015, with a 20-day weighted average stock price.

 

The Company is required to estimate potential forfeitures of stock grants and adjust stock based compensation expense accordingly. The estimate of forfeitures will be adjusted over the requisite service period to the extent that actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures will be recognized in the period of change and will also impact the amount of stock based compensation expenses to be recognized in future periods.

  

The Company recognized $28,500 and $356,729 in stock based compensation expense related to options during the six-months ended June 30, 2017 and 2016, respectively. Of these amounts, $0 and $227,784 were related to 0 and 3,796,385 options issued to employees in lieu of salaries accrued for services during the six-months ended June 30, 2017 and 2016, respectively; $0 and $66,445 were related to 0 and 1,107,417 options issued to consultants in lieu of fees accrued for services during the six-months ended June 30, 2017 and 2016, respectively; $25,000 and $62,500 were related to 161,458 and 1,041,667 options issued to directors as compensation for services during the six-months ended June 30, 2017 and 2016, respectively; and $3,500 and $0 were related to vesting of 50,000 and 0 options issued to a consultant as compensation for services during the six-months ended June 30, 2017 and 2016, respectively.